MXPA05001843A - Nuevos derivados de purina. - Google Patents
Nuevos derivados de purina.Info
- Publication number
- MXPA05001843A MXPA05001843A MXPA05001843A MXPA05001843A MXPA05001843A MX PA05001843 A MXPA05001843 A MX PA05001843A MX PA05001843 A MXPA05001843 A MX PA05001843A MX PA05001843 A MXPA05001843 A MX PA05001843A MX PA05001843 A MXPA05001843 A MX PA05001843A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- disorders
- unbranched
- branched
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
Abstract
La presente invencion se refiere a compuestos de la formula (1) o sales farmaceuticamente aceptables de los mismos, en donde uno de R1 y R2 es metilo, etilo o isopropilo, y el otro es ; R3 y R4 son cada uno independientemente H, alquilo de 1 a 6 atomos de carbono ramificada o no ramificado, o arilo, y en donde por lo menos uno de R3 y R4 es distinto a H; R5 es un grupo alquilo de 1 a 5 atomos de carbono ramificado o no ramificado o un grupo cicloalquilo de 1 a 6 atomos de carbono, cada uno de los cuales opcionalmente puede estas sustituido con uno o mas grupos OH; R6, R7, R8 y R9 son cada uno indepenmdientemente H, halogeno, NO2, OH, OMe, CN, NH2, COOH, CONH2, o SO2NH2. Un aspecto adicional de la invencion se refiere a composiciones farmaceuticas que comprenden los compuestos de la formula (1) y al uso de dichos compuestos para tratar trastornos proliferativos, trastornos virales, ataque de apoplejia, alopecia, trastornos del sistema nervioso central, trastornos neurodegenerativos, o diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0219054.4A GB0219054D0 (en) | 2002-08-15 | 2002-08-15 | New purine derivatives |
PCT/GB2003/003554 WO2004016612A2 (en) | 2002-08-15 | 2003-08-13 | New purine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05001843A true MXPA05001843A (es) | 2005-04-19 |
Family
ID=9942408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05001843A MXPA05001843A (es) | 2002-08-15 | 2003-08-13 | Nuevos derivados de purina. |
Country Status (17)
Country | Link |
---|---|
US (2) | US7582642B2 (es) |
EP (1) | EP1529047B8 (es) |
JP (1) | JP4723858B2 (es) |
CN (1) | CN1329393C (es) |
AT (1) | ATE354574T1 (es) |
AU (1) | AU2003267547B2 (es) |
BR (1) | BRPI0313477B8 (es) |
CA (1) | CA2492659C (es) |
DE (1) | DE60311995T2 (es) |
DK (1) | DK1529047T3 (es) |
ES (1) | ES2280773T3 (es) |
GB (2) | GB0219054D0 (es) |
IL (1) | IL166784A (es) |
MX (1) | MXPA05001843A (es) |
NZ (1) | NZ538135A (es) |
PT (1) | PT1529047E (es) |
WO (1) | WO2004016612A2 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
GB0012528D0 (en) * | 2000-05-23 | 2000-07-12 | Univ Palackeho | Triterpenoid derivatives |
JP4381804B2 (ja) * | 2001-06-27 | 2009-12-09 | サイクラセル リミテッド | 2,6,9−置換プリン誘導体及び増殖性疾患の治療におけるその使用 |
GB0219054D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
GB0219052D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
MX2007002169A (es) | 2004-08-27 | 2007-08-14 | Cyclacel Ltd | Inhibidores de cdk de purina y pirimidina y su uso para el tratamiento de enfermedades inmunes. |
WO2007054725A2 (en) * | 2005-11-11 | 2007-05-18 | Cyclacel Limited | Combination of a cdk-inhibitor and a hdac-inhibitor |
US7560551B2 (en) | 2006-01-23 | 2009-07-14 | Amgen Inc. | Aurora kinase modulators and method of use |
HUE028504T2 (en) | 2006-01-23 | 2016-12-28 | Amgen Inc | Aurora kinase modulators and method for their application |
US7868177B2 (en) | 2006-02-24 | 2011-01-11 | Amgen Inc. | Multi-cyclic compounds and method of use |
US8236823B2 (en) | 2006-10-27 | 2012-08-07 | Amgen Inc. | Multi-cyclic compounds and methods of use |
GB0706633D0 (en) | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | Combination |
GB0706632D0 (en) * | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | New purine derivatives |
AU2008236670B2 (en) | 2007-04-05 | 2011-12-01 | Amgen Inc. | Aurora kinase modulators and method of use |
EP2209786B1 (en) | 2007-10-05 | 2013-02-27 | Verastem, Inc. | Pyrimidine substituted purine derivatives |
WO2009117157A1 (en) | 2008-03-20 | 2009-09-24 | Amgen Inc. | Aurora kinase modulators and method of use |
US9126935B2 (en) | 2008-08-14 | 2015-09-08 | Amgen Inc. | Aurora kinase modulators and methods of use |
JP5731978B2 (ja) * | 2008-09-26 | 2015-06-10 | インテリカイン, エルエルシー | 複素環キナーゼ阻害剤 |
JP5363800B2 (ja) * | 2008-12-25 | 2013-12-11 | ライオン株式会社 | 育毛剤組成物 |
CZ302122B6 (cs) * | 2009-01-28 | 2010-10-20 | Univerzita Palackého v Olomouci | Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující |
JP5465318B2 (ja) | 2009-04-03 | 2014-04-09 | ベラステム・インコーポレーテッド | キナーゼ阻害剤としてのピリミジン置換プリン化合物 |
GB201001075D0 (en) | 2010-01-22 | 2010-03-10 | Cyclacel Ltd | Crystalline forms |
WO2013059634A1 (en) | 2011-10-20 | 2013-04-25 | The Regents Of The University Of California | Use of cdk9 inhibitors to reduce cartilage degradation |
ES2765253T3 (es) | 2014-02-17 | 2020-06-08 | Manros Therapeutics | Compuestos derivados de purina para uso médico |
AU2015333689A1 (en) | 2014-10-14 | 2017-05-25 | The Regents Of The University Of California | Use of CDK9 and BRD4 inhibitors to inhibit inflammation |
CN110248943B (zh) | 2017-01-26 | 2022-09-20 | 西克拉塞尔有限公司 | 制备嘌呤衍生物的方法 |
EP3388432A1 (en) | 2017-04-10 | 2018-10-17 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders |
GB202000901D0 (en) * | 2020-01-22 | 2020-03-04 | Cyclacel Ltd | Process |
EP3901154A1 (en) * | 2020-04-23 | 2021-10-27 | Commissariat à l'énergie atomique et aux énergies alternatives | Purine derivatives as drugs for the treatment of neonatal hypoxia-ischemia brain injury and related diseases |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2234609C (en) | 1995-11-01 | 2006-11-28 | Novartis Ag | 2-amino-6-anilino-purine derivatives and processes for their preparation |
FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
WO1998016528A1 (en) | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
EP1003746A1 (en) * | 1997-08-07 | 2000-05-31 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
AU2010399A (en) | 1997-12-24 | 1999-07-19 | Affymetrix, Inc. | Methods of using chemical libraries to search for new kinase inhibitors |
CZ291604B6 (cs) | 1998-02-26 | 2003-04-16 | Aventis Pharmaceuticals Inc. | 6,9-Disubstituované 2-[trans-(4-aminocyklohexyl)amino]puriny, farmaceutické prostředky obsahující tyto sloučeniny a použití |
ATE306487T1 (de) * | 1999-02-01 | 2005-10-15 | Cv Therapeutics Inc | Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha |
US6969720B2 (en) * | 1999-03-17 | 2005-11-29 | Amr Technology, Inc. | Biaryl substituted purine derivatives as potent antiproliferative agents |
US6627633B2 (en) * | 1999-03-17 | 2003-09-30 | Albany Molecular Research, Inc. | 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents |
JP4381804B2 (ja) * | 2001-06-27 | 2009-12-09 | サイクラセル リミテッド | 2,6,9−置換プリン誘導体及び増殖性疾患の治療におけるその使用 |
US6812232B2 (en) * | 2001-09-11 | 2004-11-02 | Amr Technology, Inc. | Heterocycle substituted purine derivatives as potent antiproliferative agents |
US6667311B2 (en) * | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
US20030229105A1 (en) * | 2002-05-21 | 2003-12-11 | Cyclacel Limited | Treatment of autoimmune disorders |
GB0219054D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
GB0219052D0 (en) * | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
GB0706632D0 (en) * | 2007-04-04 | 2007-05-16 | Cyclacel Ltd | New purine derivatives |
-
2002
- 2002-08-15 GB GBGB0219054.4A patent/GB0219054D0/en not_active Ceased
-
2003
- 2003-08-13 ES ES03748238T patent/ES2280773T3/es not_active Expired - Lifetime
- 2003-08-13 AU AU2003267547A patent/AU2003267547B2/en not_active Ceased
- 2003-08-13 CA CA2492659A patent/CA2492659C/en not_active Expired - Lifetime
- 2003-08-13 BR BRPI0313477A patent/BRPI0313477B8/pt not_active IP Right Cessation
- 2003-08-13 AT AT03748238T patent/ATE354574T1/de active
- 2003-08-13 CN CNB038194252A patent/CN1329393C/zh not_active Expired - Fee Related
- 2003-08-13 JP JP2004528667A patent/JP4723858B2/ja not_active Expired - Fee Related
- 2003-08-13 EP EP03748238A patent/EP1529047B8/en not_active Expired - Lifetime
- 2003-08-13 DE DE60311995T patent/DE60311995T2/de not_active Expired - Lifetime
- 2003-08-13 DK DK03748238T patent/DK1529047T3/da active
- 2003-08-13 MX MXPA05001843A patent/MXPA05001843A/es active IP Right Grant
- 2003-08-13 PT PT03748238T patent/PT1529047E/pt unknown
- 2003-08-13 NZ NZ538135A patent/NZ538135A/en not_active IP Right Cessation
- 2003-08-13 WO PCT/GB2003/003554 patent/WO2004016612A2/en active IP Right Grant
- 2003-08-15 GB GB0319256A patent/GB2392155B/en not_active Expired - Fee Related
-
2005
- 2005-01-11 US US11/033,692 patent/US7582642B2/en not_active Expired - Lifetime
- 2005-02-09 IL IL166784A patent/IL166784A/en active IP Right Grant
-
2009
- 2009-06-23 US US12/489,663 patent/US8846696B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2006506341A (ja) | 2006-02-23 |
BRPI0313477B8 (pt) | 2021-05-25 |
EP1529047B1 (en) | 2007-02-21 |
BRPI0313477B1 (pt) | 2019-01-22 |
EP1529047B8 (en) | 2010-05-19 |
US7582642B2 (en) | 2009-09-01 |
GB2392155A (en) | 2004-02-25 |
DE60311995D1 (de) | 2007-04-05 |
US20090325983A1 (en) | 2009-12-31 |
JP4723858B2 (ja) | 2011-07-13 |
GB0219054D0 (en) | 2002-09-25 |
CA2492659C (en) | 2012-07-17 |
GB2392155B (en) | 2005-03-30 |
AU2003267547B2 (en) | 2009-06-18 |
WO2004016612A2 (en) | 2004-02-26 |
US20050256142A1 (en) | 2005-11-17 |
IL166784A (en) | 2012-03-29 |
US8846696B2 (en) | 2014-09-30 |
ES2280773T3 (es) | 2007-09-16 |
EP1529047A2 (en) | 2005-05-11 |
PT1529047E (pt) | 2007-03-30 |
ATE354574T1 (de) | 2007-03-15 |
BR0313477A (pt) | 2005-06-21 |
WO2004016612A3 (en) | 2004-07-01 |
CN1329393C (zh) | 2007-08-01 |
IL166784A0 (en) | 2006-01-15 |
CN1675211A (zh) | 2005-09-28 |
DE60311995T2 (de) | 2007-10-31 |
AU2003267547A1 (en) | 2004-03-03 |
GB0319256D0 (en) | 2003-09-17 |
CA2492659A1 (en) | 2004-02-26 |
NZ538135A (en) | 2007-02-23 |
DK1529047T3 (da) | 2007-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166784A0 (en) | New purine derivatives | |
IL166783A0 (en) | New purine derivatives | |
AP1753A (en) | Thiophene derivatives as antiviral agents for flavvivirus infection | |
RS107504A (en) | Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compostions including the same, and methods for their use | |
MX2009003410A (es) | Fosfoindoles enantiomericamente puros como inhibidores de vih. | |
SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
MXPA06002296A (es) | Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos. | |
AP2001002241A0 (en) | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents. | |
HUP0402454A2 (hu) | Szubsztituált kinazolinszármazékok mint az aurora kinázok inhibitorai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AP2004003008A0 (en) | Piperazine derivatives with CCR1 receptor antagonist activity | |
MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
MY135841A (en) | Novel benzodioxoles | |
PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
JO2372B1 (en) | Source drugs of 4-phenylpyridine derivatives | |
DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
MXPA04000069A (es) | Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas, y metodos para su utilizacion. | |
GB0413087D0 (en) | Therapeutic compounds | |
MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
ATE487690T1 (de) | 2-aminobicyclo 3.1.0 hexan-2,6- dicarbonsäureesterderivat | |
BG105126A (en) | Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity | |
WO2004094396A3 (en) | Dihydrothiazine prodrugs of thiazolium agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |